157 related articles for article (PubMed ID: 19620774)
1. The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice.
Minami T; Yano K; Miura M; Kobayashi M; Suehiro J; Reid PC; Hamakubo T; Ryeom S; Aird WC; Kodama T
J Clin Invest; 2009 Aug; 119(8):2257-70. PubMed ID: 19620774
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium.
Minami T; Miura M; Aird WC; Kodama T
J Biol Chem; 2006 Jul; 281(29):20503-20. PubMed ID: 16627481
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor of activated T cells and early growth response-1 cooperate to mediate tissue factor gene induction by vascular endothelial growth factor in endothelial cells.
Schabbauer G; Schweighofer B; Mechtcheriakova D; Lucerna M; Binder BR; Hofer E
Thromb Haemost; 2007 Jun; 97(6):988-97. PubMed ID: 17549302
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis.
Minami T; Horiuchi K; Miura M; Abid MR; Takabe W; Noguchi N; Kohro T; Ge X; Aburatani H; Hamakubo T; Kodama T; Aird WC
J Biol Chem; 2004 Nov; 279(48):50537-54. PubMed ID: 15448146
[TBL] [Abstract][Full Text] [Related]
6. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
Yao YG; Duh EJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
[TBL] [Abstract][Full Text] [Related]
7. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP
Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650
[TBL] [Abstract][Full Text] [Related]
8. Loss of Down Syndrome Critical Region-1 Mediated-Hypercholesterolemia Accelerates Corneal Opacity Via Pathological Neovessel Formation.
Muramatsu M; Nakagawa S; Osawa T; Toyono T; Uemura A; Kidoya H; Takakura N; Usui T; Ryeom S; Minami T
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2425-2439. PubMed ID: 32787520
[TBL] [Abstract][Full Text] [Related]
9. NFAT indicates nucleocytoplasmic damped oscillation via its feedback modulator.
Muramatsu M; Ito T; Shimoji H; Komiya M; Miyamura Y; Nishiyama K; Suzuki T; Minami T
Biochem Biophys Res Commun; 2021 Sep; 571():201-209. PubMed ID: 34332425
[TBL] [Abstract][Full Text] [Related]
10. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway.
Cano E; Canellada A; Minami T; Iglesias T; Redondo JM
J Biol Chem; 2005 Aug; 280(33):29435-43. PubMed ID: 15975916
[TBL] [Abstract][Full Text] [Related]
11. Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.
Lee MY; Garvey SM; Baras AS; Lemmon JA; Gomez MF; Schoppee Bortz PD; Daum G; LeBoeuf RC; Wamhoff BR
Hum Mol Genet; 2010 Feb; 19(3):468-79. PubMed ID: 19926569
[TBL] [Abstract][Full Text] [Related]
12. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
Gollogly LK; Ryeom SW; Yoon SS
J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
[TBL] [Abstract][Full Text] [Related]
13. Loss of Down syndrome critical region-1 leads to cholesterol metabolic dysfunction that exaggerates hypercholesterolemia in ApoE-null background.
Muramatsu M; Osawa T; Miyamura Y; Nakagawa S; Tanaka T; Kodama T; Aburatani H; Sakai J; Ryeom S; Minami T
J Biol Chem; 2021; 296():100697. PubMed ID: 33895138
[TBL] [Abstract][Full Text] [Related]
14. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice.
Lange AW; Molkentin JD; Yutzey KE
Dev Biol; 2004 Feb; 266(2):346-60. PubMed ID: 14738882
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin-NFAT activation and DSCR-1 auto-inhibitory loop: how is homoeostasis regulated?
Minami T
J Biochem; 2014 Apr; 155(4):217-26. PubMed ID: 24505143
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome candidate region-1 protein interacts with Tollip and positively modulates interleukin-1 receptor-mediated signaling.
Lee JY; Lee HJ; Lee EJ; Jang SH; Kim H; Yoon JH; Chung KC
Biochim Biophys Acta; 2009 Dec; 1790(12):1673-80. PubMed ID: 19716405
[TBL] [Abstract][Full Text] [Related]
17. A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice.
Liu J; Kanki Y; Okada Y; Jin E; Yano K; Shih SC; Minami T; Aird WC
J Thromb Haemost; 2009 Aug; 7(8):1384-92. PubMed ID: 19496923
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development.
Wu H; Kao SC; Barrientos T; Baldwin SH; Olson EN; Crabtree GR; Zhou B; Chang CP
J Biol Chem; 2007 Oct; 282(42):30673-9. PubMed ID: 17693409
[TBL] [Abstract][Full Text] [Related]
19. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
Liu X; Zhao D; Qin L; Li J; Zeng H
J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614
[TBL] [Abstract][Full Text] [Related]
20. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Shin J; Lee JC; Baek KH
Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
